Liproxstatin‐1 alleviates cartilage degradation by inhibiting chondrocyte ferroptosis in the temporomandibular joint
Biology of the Cell · 2024-01 · 116 (1)
DOI: 10.1111/boc.202300042 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biology of the Cell, online erschienen am 09.11.2023. Verfasst von Bei Cheng und 5 weiteren Autor:innen. Beteiligte Einrichtung: Yunnan Key Laboratory of Stomatology, Kunming, China. Hauptthemen laut MEDLINE: Ferroptosis, Cartilage, Articular, Quinoxalines, Spiro Compounds. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: Natural Science Foundation of Yunnan Province, "Ten Thousand Talents Program" of Yunnan Province funding.
Abstract (Originalsprache)
Bground Information Ferroptosis contributes to temporomandibular joint osteoarthritis (TMJOA) lesion development and is still poorly understood.
Results
In this study, we used different TMJOA animal models to examine whether ferroptosis was related to disease onset in TMJOA induced by monosodium iodoacetate (MIA), IL‐1β, occlusion disorder (OD), and unilateral anterior crossbite (UAC). Immunohistochemical staining and Western blot analysis were used to detect ferroptosis‐ and cartilage degradation‐related protein expression. Our results revealed reduced levels of the ferroptosis‐related protein GPX4 in the cartilage layer, but the levels of ACSL4 and P53 were increased in the condyle. Injection of the ferroptosis inhibitor liproxstatin‐1 (Lip‐1) effectively decreased ACSL4, P53 and TRF expression. In vitro, IL‐1β reduced cartilage extracellular matrix expression in mandibular condylar chondrocytes (MCCs). Lip‐1 maintained the morphology and function of mitochondria and ameliorated the exacerbation of lipid peroxidation and reactive oxygen species (ROS) production induced by IL‐1β.
Conclusion
These results suggest that chondrocyte ferroptosis plays an important role in the development and progression of TMJOA. Significance Inhibiting condylar chondrocyte ferroptosis could be a promising therapeutic strategy for TMJOA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Yunnan Key Laboratory of Stomatology, Kunming, China.
- School and Hospital of Stomatology, Kunming Medical University, Kunming, China.
- Department of Stomatology, Yan'an Hospital of Kunming City, Kunming, China.
ORCID-Profile: Yu Hu
Förderung
- Natural Science Foundation of Yunnan Province
- "Ten Thousand Talents Program" of Yunnan Province funding
Zitieren
APA
Cheng, B., Zhang, J., Shen, Q., Sun, Z., Luo, Y., & Hu, Y. (2024). Liproxstatin‐1 alleviates cartilage degradation by inhibiting chondrocyte ferroptosis in the temporomandibular joint. Biology of the Cell, 116(1). https://doi.org/10.1111/boc.202300042
Vancouver
Cheng B, Zhang J, Shen Q, Sun Z, Luo Y, Hu Y. Liproxstatin‐1 alleviates cartilage degradation by inhibiting chondrocyte ferroptosis in the temporomandibular joint. Biology of the Cell. 2024;116(1). doi:10.1111/boc.202300042
BibTeX
@article{Cheng2024,
author = {Cheng, Bei and Zhang, Jun and Shen, Qinhao and Sun, Zheyi and Luo, Yingwei and Hu, Yu},
title = {Liproxstatin‐1 alleviates cartilage degradation by inhibiting chondrocyte ferroptosis in the temporomandibular joint},
journal = {Biology of the Cell},
year = {2024},
volume = {116},
number = {1},
doi = {10.1111/boc.202300042}
}
EUVIMED